Cargando…
Safety and Effectiveness of Mycophenolate in Systemic Sclerosis. A Systematic Review
BACKGROUND: Mycophenolate is increasingly being used in the rheumatic diseases. Its main adverse effects are gastrointestinal, myelosuppression, and infection. These may limit use in systemic sclerosis (SSc) since gastrointestinal involvement is common. The objective of this study is to evaluate gas...
Autores principales: | Omair, Mohammed A., Alahmadi, Abdulaziz, Johnson, Sindhu R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4416724/ https://www.ncbi.nlm.nih.gov/pubmed/25933090 http://dx.doi.org/10.1371/journal.pone.0124205 |
Ejemplares similares
-
Inflammatory Arthritis, Sacroiliitis, and Morphea: Evidence of a Systemic Inflammatory Disease
por: Omair, Mohammed A., et al.
Publicado: (2013) -
Effect and Safety of Mycophenolate Mofetil or Sodium in Systemic Sclerosis-Associated Interstitial Lung Disease: A Meta-Analysis
por: Tzouvelekis, Argyris, et al.
Publicado: (2012) -
Effectiveness and safety of mycophenolate mofetil in idiopathic pulmonary fibrosis
por: Nambiar, Anoop M., et al.
Publicado: (2017) -
Efficacy and safety of mycophenolate mofetil treatment in IgA nephropathy: a systematic review
por: Chen, Youyuan, et al.
Publicado: (2014) -
SAT-429 Systemic Safety Analysis of Mycophenolate in Graves’ Orbitopathy
por: Lee, Alan C H, et al.
Publicado: (2020)